Stilla Technologies is a french company providing digital PCR solutions (system, assays, reagents) to enable accurate quantification & detection of DNA & RNA. Our main focus is within liquid biopsie & solid tumor, as we help researchers & clinicians to detect cfDNA & monitor patient over time to detect relapse, minimal residual disease & anticipate treatment resistence. We work with hundreds of cancer centers worldwide.

CONTACT: Clément GAY, co-founder, clement.gay@stilla.fr

CEO : Rémi Dangla

WEBSITE: www.stillatechnologies.com